Indication
Additional Indications Below for Module 4 and 5
1 clinical trial
6 products
Product
AZD5305Clinical trial
A Modular Phase I/IIa, Open-label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Ascending Doses of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesStatus: Recruiting, Estimated PCD: 2026-12-15
Product
PaclitaxelProduct
CarboplatinProduct
T- DxdProduct
CamizestrantProduct
Dato-DXd